Trial Profile
neoadjuvant combined chemotherapy with gemcitabine, cisplatin and zoledronic acid against muscle invasive bladder cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 Aug 2019
Price :
$35
*
At a glance
- Drugs Zoledronic acid (Primary) ; Cisplatin; Gemcitabine
- Indications Bladder cancer
- Focus Therapeutic Use
- 07 Aug 2019 Status changed from not yet recruiting to completed.
- 13 May 2016 New trial record